SCHEMBL1697379

SCHEMBL1697379

O=C1C=C(c2ccccc2)C(c2ccccc2)O1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.51
POLB P06746 2/20 0.51
LMNA P02545 2/20 0.51
MEN1 O00255 2/20 0.51
CFTR P13569 1/20 0.44
GOPC Q9HD26 1/20 0.44
ALDH1A1 P00352 6/20 0.43
CA2 P00918 1/20 0.43
RAB9A P51151 2/20 0.41
SLC6A3 Q01959 1/20 0.41
KDM4E B2RXH2 4/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
MAPK1 P28482 1/20 0.37
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
ADK P55263 1/20 0.34
MAOB P27338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4498488 0.76 KDM4E (0.50) KMT2APOLBLMNAMEN1ALDH1A1
SCHEMBL3219657 0.74 POLB (0.44) KMT2APOLBLMNAMEN1CFTR
SCHEMBL5261044 0.74 LMNA (0.44) KMT2APOLBLMNAMEN1CFTR
SCHEMBL6221726 0.74 ADK (0.36) KMT2APOLBLMNAMEN1CFTR
SCHEMBL10533490 0.72 ALDH1A1 (0.44) KMT2APOLBLMNAMEN1ALDH1A1
SCHEMBL6702897 0.72 POLB (0.42) KMT2APOLBLMNAMEN1CFTR
SCHEMBL18866755 0.72 LMNA (0.42) KMT2APOLBLMNAMEN1CFTR
SCHEMBL31650964 0.69 ALDH1A1 (0.56) KMT2APOLBLMNAMEN1ALDH1A1
SCHEMBL10481123 0.69 KDM4E (0.56) KMT2APOLBLMNAMEN1ALDH1A1
SCHEMBL27535433 0.69 KMT2A (0.40) KMT2APOLBLMNAMEN1CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10113052-B2 5H-furan-2-one derivatives stabilization of organic material BASF SE (DE) 2018-10-30 US disclosed
US-20160362535-A1 5H-FURAN-2-ONE DERIVATIVES STABILIZATION OF ORGANIC MATERIAL BASF SCHWEIZ AG (CH) 2016-12-15 US disclosed
US-20160362535-A1 5H-FURAN-2-ONE DERIVATIVES STABILIZATION OF ORGANIC MATERIAL BASF SCHWEIZ AG (CH) 2016-12-15 US disclosed
US-20160362535-A1 5H-FURAN-2-ONE DERIVATIVES STABILIZATION OF ORGANIC MATERIAL BASF SCHWEIZ AG (CH) 2016-12-15 US disclosed
US-9458380-B2 5H-furan-2-one derivatives for stabilization of organic material BASF SE (DE) 2016-10-04 US disclosed
US-9458380-B2 5H-furan-2-one derivatives for stabilization of organic material BASF SE (DE) 2016-10-04 US disclosed
US-9458380-B2 5H-furan-2-one derivatives for stabilization of organic material BASF SE (DE) 2016-10-04 US disclosed
EP-2705082-B1 5H-FURAN-2-ONE DERIVATIVES FOR STABILIZATION OF ORGANIC MATERIAL BASF SE (DE) 2015-09-23 EP disclosed
EP-2705082-A1 5H-FURAN-2-ONE DERIVATIVES FOR STABILIZATION OF ORGANIC MATERIAL BASF SE (DE) 2014-03-12 EP disclosed
US-20140058021-A1 5H-Furan-2-one Derivatives for Stabilization of Organic Material BASF SE (DE) 2014-02-27 US disclosed
US-20140058021-A1 5H-Furan-2-one Derivatives for Stabilization of Organic Material BASF SE (DE) 2014-02-27 US disclosed
US-20140058021-A1 5H-Furan-2-one Derivatives for Stabilization of Organic Material BASF SE (DE) 2014-02-27 US disclosed
US-20130123537-A1 PROCESS FOR THE PREPARATION OF LACOSAMIDE AUROBINDO PHARMA LTD. (IN) 2013-05-16 US disclosed
WO-2012150527-A1 5H-FURAN-2-ONE DERIVATIVES FOR STABILIZATION OF ORGANIC MATERIAL BASF SE (DE) 2012-11-08 WO disclosed
WO-2012150527-A1 5H-FURAN-2-ONE DERIVATIVES FOR STABILIZATION OF ORGANIC MATERIAL BASF SE (DE) 2012-11-08 WO disclosed
WO-2011144983-A2 AN IMPROVED PROCESS FOR THE PREPARATION OF LACOSAMIDE AUROBINDO PHARMA LIMITED (IN) 2011-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130123537-A1 PROCESS FOR THE PREPARATION OF LACOSAMIDE MYT1, TET1, LPXN KMT2A 31/4885POLB 1055/4885LMNA 878/4885
US-10113052-B2 5H-furan-2-one derivatives stabilization of organic material C5, C9, CBR1 KMT2A 3534/4885POLB 1203/4885LMNA 325/4885
US-20160362535-A1 5H-FURAN-2-ONE DERIVATIVES STABILIZATION OF ORGANIC MATERIAL C5, C9, CBR1 KMT2A 3534/4885POLB 1203/4885LMNA 325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.